The introduction of monoclonal antibodies has heralded a new era in treating chronic lymphocytic leukemia (CLL); Rituximab has moved into frontline CLL drug combinations, and Campath-1H has been approved for salvage therapy. Our group has been actively pursuing the pre-clinical and clinical development of a humanized HLA-DR beta-chain antibody, Hu1D10. Our preliminary studies have demonstrated that Hu1D10 induces apoptosis in a caspase-independent pathway involving generation of reactive oxygen species, release of apoptosis-inducing factor, and activation of ly/syk. While our data support the importance of HLA-DR signaling in the apoptotic effect of this therapy, AKT is also activated by this therapy. Furthermore, combination of Hu1D10 with inhibitors of PI3 kinase results in synergistic apoptosis. These findings suggest that dual survival and death signals are being generated by Hu1D10 therapy. Concurrent with these investigations, we have nearly completed a phase I trial with pharmacokinetic studies suggesting that the rate of clearance of Hu1D10 is directly proportional to 1D10 antigen on the CLL cells. If this observation is confirmed, it might be possible to dose Hu1D10 based upon pre-treatment density of tumor 1D10 antigen expression. In addition, we have seen clinical activity in resistant CLL possessing a del(17p13.1) chromosomal abnormality. Based upon these promising data, continued development of Hu1D10 and other pan HLA-DR antibodies is planned. This proposal seeks support of a multi-modality effort to perform detailed clinical and laboratory investigation of Hu1D10 in CLL. Our four aims are to determine 1) the clinical activity, toxicity, and pharmacology of this targeted therapy in genetically characterized CLL patients, 2) the importance of ROS generation, signal transduction, and genetic subtype to the cytotoxic effect mediated by Hu1D10, 3) properties that convey resistance to Hu1D10 in CLL, and 4) the most promising combination strategies with Hu1D10 for future phase I trials. Performance of these clinical and laboratory studies related to Hu1D10 in CLL by this multifaceted group will facilitate optimal and safe development of this agent and potentially other HLA-DR-directed antibodies that will soon be entering clinical trials for hematologic malignancies and solid tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA102504-02
Application #
6796363
Study Section
Clinical Oncology Study Section (CONC)
Program Officer
Wu, Roy S
Project Start
2003-09-01
Project End
2007-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$291,975
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Habermann, Nina; Makar, Karen W; Abbenhardt, Clare et al. (2015) No effect of caloric restriction or exercise on radiation repair capacity. Med Sci Sports Exerc 47:896-904
Mason, Caitlin; Xiao, Liren; Imayama, Ikuyo et al. (2015) The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial. Clin Endocrinol (Oxf) 82:369-76
Duggan, Catherine; Xiao, Liren; Terry, Mary Beth et al. (2014) No effect of weight loss on LINE-1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women. Obesity (Silver Spring) 22:2091-6
Mason, Caitlin; Foster-Schubert, Karen E; Imayama, Ikuyo et al. (2013) History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism 62:127-36
Mason, Caitlin; Xiao, Liren; Duggan, Catherine et al. (2013) Effects of dietary weight loss and exercise on insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in postmenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 22:1457-63
Abbenhardt, C; McTiernan, A; Alfano, C M et al. (2013) Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med 274:163-75
Mason, Caitlin; Xiao, Liren; Imayama, Ikuyo et al. (2013) Influence of diet, exercise, and serum vitamin d on sarcopenia in postmenopausal women. Med Sci Sports Exerc 45:607-14
Mason, Caitlin; Risques, Rosa-Ana; Xiao, Liren et al. (2013) Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 21:E549-54
Foster-Schubert, Karen E; Alfano, Catherine M; Duggan, Catherine R et al. (2012) Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring) 20:1628-38
Campbell, Kristin L; Foster-Schubert, Karen E; Alfano, Catherine M et al. (2012) Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 30:2314-26

Showing the most recent 10 out of 15 publications